# reload+after+2024-01-21 14:44:48.074549
address1§4978 Santa Anita Avenue
city§Temple City
state§CA
zip§91780
country§United States
phone§626 350 0537
fax§626 454 1667
website§https://www.fulgentgenetics.com
industry§Diagnostics & Research
sector§Healthcare
longBusinessSummary§Fulgent Genetics, Inc., together with its subsidiaries, provides clinical diagnostic and therapeutic development solutions to physicians and patients in the United States and internationally. The company's clinical diagnostic solutions include molecular diagnostic testing; genetic testing; anatomic pathology laboratory tests and testing services, such as gastrointestinal pathology, dermatopathology, urologic pathology, breast pathology, neuropathology, and hematopathology; oncology tests and testing services; and next generation sequencer services related to hereditary cancer, cardiovascular genetics, reproductive health, and neurodegenerative genetics, as well as pharmacogenetic tests. Its therapeutic development solutions focus on developing drug candidates for treating a range of cancers using a novel nanoencapsulation and targeted therapy platform designed to enhance the therapeutic window and pharmacokinetic profile, or PK profile, of new and existing cancer drugs. The company also operates picture genetics platform which includes proprietary gene probes, data suppression and comparison algorithms, adaptive learning software, and proprietary laboratory information management systems that helps customers to identify health markers in their personal DNA. It serves insurance, hospitals, medical institutions, other laboratories, governmental bodies, payors, municipalities and large corporations, and patients. The company was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016. Fulgent Genetics, Inc. was founded in 2011 and is headquartered in Temple City, California.
fullTimeEmployees§1012
companyOfficers§[{'maxAge': 1, 'name': 'Mr. Ming  Hsieh', 'age': 67, 'title': 'Chairman & CEO', 'yearBorn': 1956, 'fiscalYear': 2022, 'totalPay': 1661473, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Jian  Xie', 'age': 57, 'title': 'COO & President', 'yearBorn': 1966, 'fiscalYear': 2022, 'totalPay': 755726, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Paul  Kim', 'age': 56, 'title': 'Chief Financial Officer', 'yearBorn': 1967, 'fiscalYear': 2022, 'totalPay': 757587, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Han Lin Gao D.A.B.M.G., FACMG, M.D., Ph.D.', 'age': 56, 'title': 'Chief Scientific Officer & Laboratory Director', 'yearBorn': 1967, 'fiscalYear': 2022, 'totalPay': 630608, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Natalie  Prescott', 'title': 'General Counsel & Chief Privacy Officer', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Doreen  Ng', 'title': 'VP of Operations & Compliance and GM of Houston Office', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Jakub  Sram', 'title': 'Vice President of Business Development & Sales', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Ellen  Tsui', 'title': 'Vice President of Human Resources', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Brandon  Perthuis', 'title': 'Chief Commercial Officer', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Lawrence M. Weiss M.D.', 'age': 66, 'title': 'Chief Medical Officer', 'yearBorn': 1957, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
auditRisk§2
boardRisk§7
compensationRisk§8
shareHolderRightsRisk§4
overallRisk§5
governanceEpochDate§1704067200
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§2
payoutRatio§0.0
beta§1.544
priceToSalesTrailing12Months§2.9155927
currency§USD
dateShortInterest§1702598400
forwardEps§-0.95
pegRatio§0.56
exchange§NGM
quoteType§EQUITY
shortName§Fulgent Genetics, Inc.
longName§Fulgent Genetics, Inc.
firstTradeDateEpochUtc§1475155800
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§32ef4e17-830f-3fca-bfab-78b786b069a6
gmtOffSetMilliseconds§-18000000
targetHighPrice§35.0
targetLowPrice§28.0
targetMeanPrice§32.67
targetMedianPrice§35.0
recommendationMean§2.7
recommendationKey§hold
numberOfAnalystOpinions§3
quickRatio§8.506
grossMargins§0.32196
ebitdaMargins§-0.13128
trailingPegRatio§None
